Ian E. Anglin
Impact in
- Urology top 10%
- Urinary Bladder and Prostate Research
-
- Cancer, Hypoxia, and Metabolism
Papers in ⓘ
-
- Ubiquitin and proteasome pathways 2
- Oncology 3
- Co-authors
- Natasha Kyprianou (2 shared papers)James Partin (1 shared paper)Deborah T. Glassman (1 shared paper)Antonino Passaniti (4 shared papers)Michele Vítolo (3 shared papers)William M. Mahoney (1 shared paper)Ronald B. Gartenhaus (1 shared paper)Toni Antalis (2 shared papers)
- Journals
- Journal of Cellular Biochemistry (1 paper)Cancer Biology & Therapy (1 paper)The Journal of Immunology (1 paper)British Journal of Cancer (1 paper)Vaccine (1 paper)
- Partner nations
- United StatesAustraliaThailand
In The Last Decade
Ian E. Anglin
11 papers receiving 450 citations
Peers
Comparison fields: 5 of 78
- Urology 41
- Cancer Research 93
- Cell Biology 92
- Molecular Biology 260
- Immunology and Allergy 21
Countries citing papers authored by Ian E. Anglin
This map shows the geographic impact of Ian E. Anglin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian E. Anglin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian E. Anglin more than expected).
Fields of papers citing papers by Ian E. Anglin
This network shows the impact of papers produced by Ian E. Anglin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian E. Anglin. The network helps show where Ian E. Anglin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian E. Anglin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 92 | |
| 2 | 2002 | 65 | |
| 3 | 2007 | 63 | |
| 4 | 2008 | 52 | |
| 5 | 2001 | 50 | |
| 6 | 2004 | 41 | |
| 7 | 2013 | 31 | |
| 8 | 2011 | 26 | |
| 9 | 2006 | 19 | |
| 10 | 2011 | 17 | |
| 11 | 2017 | 5 |
About Ian E. Anglin
Ian E. Anglin is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Cancer Research, having authored 11 papers that have together received 461 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (2 papers), Prostate Cancer Treatment and Research (2 papers), Acute Myeloid Leukemia Research (2 papers), NF-κB Signaling Pathways (2 papers), Ubiquitin and proteasome pathways (2 papers), interferon and immune responses (1 paper), Calpain Protease Function and Regulation (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Urology (41 citations), Cancer Research (93 citations), Cell Biology (92 citations), Molecular Biology (260 citations) and Immunology and Allergy (21 citations). Ian E. Anglin has collaborated with scholars based in United States, Australia and Thailand. Frequent co-authors include Natasha Kyprianou, James Partin, Deborah T. Glassman, Antonino Passaniti, Michele Vítolo, William M. Mahoney, Ronald B. Gartenhaus, Toni Antalis, Kurtis E. Bachman and Sarah Netzel–Arnett. Their work appears in journals such as Journal of Cellular Biochemistry, Cancer Biology & Therapy, The Journal of Immunology, British Journal of Cancer and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.